Pharmaids Pharmaceuticals Limited (BOM:524572)
India · Delayed Price · Currency is INR 30.77
-0.23 (-0.74%)
At close: Apr 16, 2026
Pharmaids Pharmaceuticals Market Cap
Pharmaids Pharmaceuticals has a market cap or net worth of 1.09 billion as of April 16, 2026. Its market cap has decreased by -55.68% in one year.
Market Cap
1.09B
Enterprise Value
1.28B
Revenue
255.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.77
Market Cap Chart
Since January 11, 2002, Pharmaids Pharmaceuticals's market cap has increased from 12.26M to 1.09B, an increase of 8,751.62%. That is a compound annual growth rate of 20.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 1.09B | -34.96% |
| Dec 31, 2025 | 1.68B | -32.38% |
| Dec 31, 2024 | 2.49B | 137.65% |
| Dec 29, 2023 | 1.05B | 185.46% |
| Dec 26, 2022 | 366.41M | 131.65% |
| Dec 31, 2021 | 158.17M | -6.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bilcare | 1.45B |
| Coral Laboratories | 1.44B |
| Speciality Medicines | 1.43B |
| Bal Pharma | 1.19B |
| Lactose (India) | 1.15B |
| Concord Drugs | 1.02B |
| Mercury Laboratories | 924.00M |
| Makers Laboratories | 919.28M |